The Risks of MDS

When MDS is diagnosed what are some treatment considerations. So first you want to see how significant are the cytopenias and are they transfusion dependent, and then you also want to assess their risk score in terms of cytogenetics and molecular markers. Good features are if you have a hemoglobin more than 10 platelets more than 100 ANC more than 0.8 and blast less than 2% and bad features are ifYou have a platelet less than 50 ANC less than 0. 8 hemoglobin less than 8 and blast more than 5 to 10%.